Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Antinuclear Antibody Tests Market Portraiture
2.1.1. Global Antinuclear Antibody Tests Market, by Product Type, 2016
2.1.2. Global Antinuclear Antibody Tests Market, by Technique Type, 2016
2.1.3. Global Antinuclear Antibody Tests Market, by Disease Type, 2016
2.1.4. Global Antinuclear Antibody Tests Market, by Geography, 2016
Chapter 3. Antinuclear Antibody Tests: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Antinuclear Antibody Tests Market, by Product Type
4.3. Reagents & Assay Kits
4.4. Software & Services
4.5. Systems
Chapter 5. Global Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global Antinuclear Antibody Tests Market, by Technique Type
5.3. ELISA
5.4. Immunofluorescence Assay
5.5. Multiplex Assay
Chapter 6. Global Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Attractive Investment Proposition: Global Antinuclear Antibody Tests Market, by Disease Type
6.3. Rheumatoid Arthritis
6.4. Scleroderma
6.5. Systemic Lupus Erythematosus
6.6. Sjögren’s Syndrome
6.7. Other Diseases
Chapter 7. Global Antinuclear Antibody Tests Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Antinuclear Antibody Tests Market Analysis, 2015 – 2025
7.2.1. North America Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
7.2.3. North America Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.2.4. North America Antinuclear Antibody Tests Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Antinuclear Antibody Tests Market Analysis, 2015 – 2025
7.3.1. Europe Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
7.3.3. Europe Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.3.4. Europe Antinuclear Antibody Tests Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. France
7.3.4.4. Rest of Europe
7.4. Asia Pacific Antinuclear Antibody Tests Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Antinuclear Antibody Tests Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America Antinuclear Antibody Tests Market Analysis, 2015 – 2025
7.5.1. Latin America Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Antinuclear Antibody Tests Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Antinuclear Antibody Tests Market Analysis, 2015 – 2025
7.6.1. MEA Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
7.6.3. MEA Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.6.4. MEA Antinuclear Antibody Tests Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. UAE
7.6.4.2. Saudi Arabia
7.6.4.3. South Africa
7.6.4.4. Rest of MEA
Chapter 8. Company Profiles
8.1. Alere, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Abbott Laboratories
8.3. Antibodies, Inc.
8.4. Bio-Rad Laboratories, Inc.
8.5. Biocom Biotech
8.6. Erba Diagnostics, Inc.
8.7. Euroimmun AG
8.8. HUMAN Diagnostics, Inc.
8.9. Immuno Concepts, Inc.
8.10. Inova Diagnostics, Inc.
8.11. Thermo Fisher Scientific, Inc.
8.12. Trinity Biotech Plc
8.13. Zeus Scientific, Inc.
8.14. Other Notable Players
List of Figures
FIG. 1 Antinuclear Antibody Tests : Market Segmentation
FIG. 2 Global Antinuclear Antibody Tests Market Share, by Product Type, 2016 (US$ Mn)
FIG. 3 Global Antinuclear Antibody Tests Market Share, by Technique Type, 2016 (US$ Mn)
FIG. 4 Global Antinuclear Antibody Tests Market Share, by Disease Type, 2016 (US$ Mn)
FIG. 5 Global Antinuclear Antibody Tests Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Antinuclear Antibody Reagents & Assay Kits Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Antinuclear Antibody Systems Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Antinuclear Antibody Software and Services Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Elisa Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Immunofluorescence Assay Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Multiplex Assay Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Antinuclear Antibody Tests for Rheumatoid Arthritis Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Antinuclear Antibody Tests for Systemic Lupus Erythematosus Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Antinuclear Antibody Tests for Sjögren’s Syndrome Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global Antinuclear Antibody Tests for Scleroderma Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Antinuclear Antibody Tests for Other Diseases Market, 2015 – 2025 (US$ Mn)
FIG. 19 U.S. Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 20 Canada Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 21 U.K. Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 22 Germany Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 23 France Antinuclear Antibody Tests Market, 2015-2025 (US$ Mn)
FIG. 24 Rest of Europe Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 25 Japan Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 26 China Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 27 India Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Asia Pacific Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 29 Brazil Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 30 Mexico Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest of Latin America Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 32 UAE Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 33 Saudi Arabia Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 34 South Africa Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
FIG. 35 Rest of Middle East and Africa Antinuclear Antibody Tests Market, 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Antinuclear Antibody Tests Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Antinuclear Antibody Tests Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 13 Asia Pacific Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025(US$ Mn)
TABLE 14 Asia Pacific Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025(US$ Mn)
TABLE 15 Asia Pacific Antinuclear Antibody Tests Market, by Country, 2015 – 2025(US$ Mn)
TABLE 16 Latin America Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 17 Latin America Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025(US$ Mn)
TABLE 18 Latin America Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025(US$ Mn)
TABLE 19 Latin America Antinuclear Antibody Tests Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Antinuclear Antibody Tests Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Antinuclear Antibody Tests Market, by Technique Type, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Antinuclear Antibody Tests Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Antinuclear Antibody Tests Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 24 Alere, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 25 Abbott Laboratories: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 26 Antibodies, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 27 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 28 Biocom Biotech: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 29 Erba Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 30 Euroimmun AG: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 31 HUMAN Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 32 Immuno Concepts, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 33 Inova Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 34 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 35 Trinity Biotech Plc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 36 Zeus Scientific, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)